Zimmer Biomet Holdings (ZBH) Stock Statistics & Valuation Metrics

Zimmer Biomet Holdings has a market cap or net worth of MXN 338.68B. The enterprise value is MXN 23.68B.

Market Cap

MXN 338.68B

Enterprise Value

MXN 23.68B

Zimmer Biomet Holdings has 190,737,690 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

190,737,690

Owned by Insiders

0.17%

Owned by Institutions

76.77%

Zimmer Biomet Holdings’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.48%.

Return on Equity (ROE)

0.06

Return on Assets (ROA)

0.03

Return on Invested Capital (ROIC)

5.48%

Return on Capital Employed (ROCE)

0.07

Revenue Per Employee

484.21K

Profits Per Employee

41.48K

Employee Count

17,000

Asset Turnover

0.36

Inventory Turnover

1.38

The current PE Ratio of Zimmer Biomet Holdings is 22.89. Zimmer Biomet Holdings’s PEG ratio is 94.29.

PE Ratio

22.89

PS Ratio

2.12

PB Ratio

1.44

Price to FCF

9.85

Price to Operating Cash Flow

10.42

PEG Ratio

94.29

In the last 12 months, Zimmer Biomet Holdings had revenue of 8.23B and earned 705.20M in profits. Earnings per share was 3.56.

Revenue

8.23B

Gross Profit

5.07B

Operating Income

1.36B

Pretax Income

830.80M

Net Income

705.20M

EBITDA

2.22B

Earnings Per Share (EPS)

3.56

In the last 12 months, operating cash flow was 1.74B and capital expenditures 86.80M, giving a free cash flow of 1.83B billion.

Operating Cash Flow

1.74B

Free Cash Flow

1.83B

Free Cash Flow per Share

9.52

Zimmer Biomet Holdings pays an annual dividend of ―, resulting in a dividend yield of 1.08%

Dividend Per Share

―

Dividend Yield

1.08%

Payout Ratio

N/A

Free Cash Flow Yield

10.15%

Earnings Yield

4.44%

Beta

0.05

52-Week Price Change

-7.73%

50-Day Moving Average

1575.63

200-Day Moving Average

1547.34

Relative Strength Index (RSI)

81.95

Average Volume (3m)

91

Zimmer Biomet Holdings upcoming earnings date is Nov 04, 2026, Before Open (Not Confirmed).

Last Earnings Date

Aug 05, 2026

Next Earnings Date

Nov 04, 2026

Ex-Dividend Date

―

Zimmer Biomet Holdings as a current ratio of 1.98, with Debt / Equity ratio of 59.22%

Current Ratio

1.98

Quick Ratio

1.10

Debt to Market Cap

0.42

Net Debt to EBITDA

3.12

Interest Coverage Ratio

4.65

In the past 12 months, Zimmer Biomet Holdings has paid 125.70M in taxes.

Income Tax

125.70M

Effective Tax Rate

0.15

Zimmer Biomet Holdings EV to EBITDA ratio is 10.74, with an EV/FCF ratio of 13.71.

EV to Sales

2.95

EV to EBITDA

10.74

EV to Free Cash Flow

13.71

EV to Operating Cash Flow

14.40

Zimmer Biomet Holdings has MXN 410.00M in cash and marketable securities with MXN 7.48B in debt, giving a net cash position of -MXN 7.07B billion.

Cash & Marketable Securities

MXN 410.00M

Total Debt

MXN 7.48B

Net Cash

-MXN 7.07B

Net Cash Per Share

-MXN 37.06

Tangible Book Value Per Share

-MXN 9.10

Gross margin is 69.87%, with operating margin of 15.73%, and net profit margin of 9.48%.

Gross Margin

69.87%

Operating Margin

15.73%

Pretax Margin

10.97%

Net Profit Margin

9.48%

EBITDA Margin

27.47%

EBIT Margin

14.44%

The average price target for Zimmer Biomet Holdings is MXN 1,979.34, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

MXN 1,979.34

Price Target Upside

21.88% Upside

Analyst Consensus

Moderate Buy

Analyst Count

20

Revenue Growth Forecast

-1.19%

EPS Growth Forecast

-8.85%

Smart Score

8

AI Score

―